Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma

Human Pathology

Volumn 43, Issue 10, 2012, Pages 1552-1558

  Kipp, Benjamin R ^a   Voss, Jesse S ^a   Kerr, Sarah E ^a   Barr Fritcher, Emily G ^a   Graham, Rondell P ^a   Zhang, Lizhi ^a   Edward Highsmith, W ^a   Zhang, Jun ^a   Roberts, Lewis R ^a   Gores, Gregory J ^a   Halling, Kevin C ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

2 hydroxyglutarate; Bile duct; Biliary tract; Cholangiocarcinoma; Isocitrate dehydrogenase

Indexed keywords

BIOLOGICAL MARKER; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DIFFERENTIATION; CLEAR CELL CARCINOMA; CODON; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EXON; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOCITRATE DEHYDROGENASE 1 GENE; ISOCITRATE DEHYDROGENASE 2 GENE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PYROSEQUENCING; TUMOR CELL;

BASE SEQUENCE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; ISOCITRATE DEHYDROGENASE; MALE; MIDDLE AGED; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84866504465     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.12.007     Document Type: Article

References (28)

1. K.N. Lazaridis, and G.J. Gores Cholangiocarcinoma Gastroenterology 128 2005 1655 1667 (Pubitemid 40692558)
2. B. Blechacz, and G.J. Gores Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 2008 308 321 (Pubitemid 351975555)
3. C.B. Rosen, J.K. Heimbach, and G.J. Gores Liver transplantation for cholangiocarcinoma Transpl Int 23 2010 692 697
4. N. Akamatsu, Y. Sugawara, and D. Hashimoto Surgical strategy for bile duct cancer: advances and current limitations World J Clin Oncol 2 2011 94 107
5. M. Gatto, and D. Alvaro New insights on cholangiocarcinoma World J Gastrointest Oncol 2 2010 136 145
6. T. Patel Cholangiocarcinoma - controversies and challenges Nat Rev Gastroenterol Hepatol 8 2011 189 200
7. E.G. Fritcher, B.R. Kipp, and K.C. Halling A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures Gastroenterology 136 2009 2180 2186
8. R.D. Prasasya, D. Tian, and P.K. Kreeger Analysis of cancer signaling networks by systems biology to develop therapies Semin Cancer Biol 21 2011 200 206
9. H. Yan, D.W. Parsons, and G. Jin IDH1 and IDH2 mutations in gliomas N Engl J Med 360 2009 765 773
10. T. Watanabe, S. Nobusawa, P. Kleihues, and H. Ohgaki IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas Am J Pathol 174 2009 1149 1153
11. A. Tefferi, T.L. Lasho, and O. Abdel-Wahab IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis Leukemia 24 2010 1302 1309
12. M. Sanson, Y. Marie, and S. Paris Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas J Clin Oncol 27 2009 4150 4154
13. Z.J. Reitman, D.W. Parsons, and H. Yan IDH1 and IDH2: not your typical oncogenes Cancer Cell 17 2010 215 216
14. K. Ichimura, D.M. Pearson, and S. Kocialkowski IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas Neuro Oncol 11 2009 341 347
15. C. Hartmann, J. Meyer, and J. Balss Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas Acta Neuropathol 118 2009 469 474
16. F.E. Bleeker, S. Lamba, and S. Leenstra IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors Hum Mutat 30 2009 7 11
17. B. Pietrak, H. Zhao, and H. Qi A tale of two subunits: how the neomorphic R132H IDH1 mutation enhances production of alphaHG Biochemistry 50 2011 4804 4812
18. L. Dang, D.W. White, and S. Gross Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 2009 739 744
19. P.S. Ward, J. Patel, and D.R. Wise The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate Cancer Cell 17 2010 225 234
20. Z.J. Reitman, G. Jin, and E.D. Karoly Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome Proc Natl Acad Sci U S A 108 2011 3270 3275
21. J. Balss, J. Meyer, W. Mueller, A. Korshunov, C. Hartmann, and A. von Deimling Analysis of the IDH1 codon 132 mutation in brain tumors Acta Neuropathol 116 2008 597 602
22. D.W. Parsons, S. Jones, and X. Zhang An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
23. J.R. Prensner, and A.M. Chinnaiyan Metabolism unhinged: IDH mutations in cancer Nat Med 17 2011 291 293
24. K.E. Yen, M.A. Bittinger, S.M. Su, and V.R. Fantin Cancer-associated IDH mutations: biomarker and therapeutic opportunities Oncogene 29 2010 6409 6417
25. F. Damm, F. Thol, and I. Hollink Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups Leukemia 25 2011 1704 1710
26. M.F. Amary, K. Bacsi, and F. Maggiani IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours J Pathol 224 2011 334 343
27. R. Chowdhury, K.K. Yeoh, and Y.M. Tian The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases EMBO Rep 12 2011 463 469
28. F. Sahm, D. Capper, and S. Pusch Detection of 2-hydroxyglutarate in formalin-fixed paraffin-embedded glioma specimens by gas-chromatography/mass- spectrometry Brain Pathol 2011 [In Press]